Timing and Timeliness in Medical Care Evaluation Bernard S. BloomA. Mark Fendrick Current Opinion 17 September 2012 Pages: 183 - 187
The Pharmacoeconomics of ACE Inhibitors in Chronic Heart Failure John McMurrayAndrew Davie Leading Article 17 September 2012 Pages: 188 - 197
Outcomes Assessment of Drug Treatment in Multiple Sclerosis Clinical Trials Margaret MaloneBen Lomaestro Review Article 17 September 2012 Pages: 198 - 210
Cost-Effective Policies for Cervical Cancer Screening Marianne C. FahsStacey B. PlichtaJeanne S. Mandelblatt Review Article 17 September 2012 Pages: 211 - 230
Direct Costs of Osteoporosis For New Zealand Women Annika Lane Original Research Article 17 September 2012 Pages: 231 - 245
Drug Use in Relation to Clinical Activities as an Instrument for Prospective Drug Budgeting Marie-Christine ClosonRalph CrottDanièle Even-Adin Original Research Article 17 September 2012 Pages: 246 - 263
A Strategy for Collecting Pharmacoeconomic Data During Phase II/III Clinical Trials Josephine MauskopfKevin SchulmanHenry Glick Special Article 17 September 2012 Pages: 264 - 277